Maintenance Therapy in Nonsmall-Cell Lung Cancer: A New Treatment ParadigmMOK, Tony S. K; RAMALINGAM, Suresh S.Cancer. 2009, Vol 115, Num 22, pp 5143-5154, issn 0008-543X, 12 p.Article

ALK-Positive Non-Small Cell Lung Cancer: Mechanisms of Resistance and Emerging Treatment OptionsSTEUER, Conor E; RAMALINGAM, Suresh S.Cancer. 2014, Vol 120, Num 16, pp 2392-2402, issn 0008-543X, 11 p.Article

Gene expression profiling of Non-small cell lung cancerSINGHAL, Sunil; MILLER, Daniel; RAMALINGAM, Suresh et al.Lung cancer. 2008, Vol 60, Num 3, pp 313-324, issn 0169-5002, 12 p.Article

Maintenance Therapy for Advanced Non-small Cell Lung Cancer: Current Status, Controversies, and Emerging ConsensusOWONIKOKO, Taofeek K; RAMALINGAM, Suresh S; BELANI, Chandra P et al.Clinical cancer research (Print). 2010, Vol 16, Num 9, pp 2496-2504, issn 1078-0432, 9 p.Article

A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non―Small Cell Lung CancerSOCINSKI, Mark A; GOLDMAN, Jonathan; BONOMI, Philip et al.Clinical cancer research (Print). 2013, Vol 19, Num 11, pp 3068-3077, issn 1078-0432, 10 p.Article

Phase I and Pharmacokinetic Study of Pegylated Liposomal CKD-602 in Patients with Advanced MalignanciesZAMBONI, William C; RAMALINGAM, Suresh; FRIEDLAND, David M et al.Clinical cancer research (Print). 2009, Vol 15, Num 4, pp 1466-1472, issn 1078-0432, 7 p.Article

Significance of EGFR protein expression and gene amplification in non-small cell lung carcinomaDACIC, Sanja; FLANAGAN, Melina; CIEPLY, Kathleen et al.American journal of clinical pathology. 2006, Vol 125, Num 6, pp 860-865, issn 0002-9173, 6 p.Article

An open-label study to describe pharmacokinetic parameters of erlotinib in patients with advanced solid tumors with adequate and moderately impaired hepatic functionO'BRYANT, Cindy L; HALUSKA, Paul; BELANI, Chandra et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 3, pp 605-612, issn 0344-5704, 8 p.Article

Comparison of Outcomes for Elderly Patients Treated With Weekly Paclitaxel in Combination With Carboplatin Versus the Standard 3-Weekly Paclitaxel and Carboplatin for Advanced Nonsmall Cell Lung CancerRAMALINGAM, Suresh; PERRY, Michael C; LA ROCCA, Renato V et al.Cancer. 2008, Vol 113, Num 3, pp 542-546, issn 0008-543X, 5 p.Article

Retinoic Acid Enhances TRAIL-Induced Apoptosis in Cancer Cells by Upregulating TRAIL Receptor 1 ExpressionDHANDAPANI, Latha; PING YUE; RAMALINGAM, Suresh S et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 15, pp 5245-5254, issn 0008-5472, 10 p.Article

A liquid chromatography-electrospray ionization tandem mass spectrometric assay for quantitation of the histone deacetylase inhibitor, vorinostat (suberoylanilide hydroxamicacid, SAHA), and its metabolites in human serumPARISE, Robert A; HOLLERAN, Julianne L; BEUMER, Jan H et al.Journal of chromatography. B. 2006, Vol 840, Num 2, pp 108-115, issn 1570-0232, 8 p.Article

Phase 2 Study of Irinotecan and Paclitaxel in Patients With Recurrent or Refractory Small Cell Lung CancerRAMALINGAM, Suresh S; FOSTER, Judy; GOODING, William et al.Cancer. 2010, Vol 116, Num 5, pp 1344-1349, issn 0008-543X, 6 p.Article

Adenoid Cystic Carcinoma of the Head and Neck: Incidence and Survival Trends Based on 1973-2007 Surveillance, Epidemiology, and End Results DataELLINGTON, Christopher L; GOODMAN, Michael; BEITLER, Jonathan J et al.Cancer. 2012, Vol 118, Num 18, pp 4444-4451, issn 0008-543X, 8 p.Article

Diallyl Trisulfide Selectively Causes Bax-and Bak-Mediated Apoptosis in Human Lung Cancer CellsDONG XIAO; YAN ZENG; HAHM, Eun-Ryeong et al.Environmental and molecular mutagenesis (Print). 2009, Vol 50, Num 3, pp 201-212, issn 0893-6692, 12 p.Article

Radiosurgery for the treatment of spinal lung metastasesGERSZTEN, Peter C; BURTON, Steven A; BELANI, Chandra P et al.Cancer. 2006, Vol 107, Num 11, pp 2653-2661, issn 0008-543X, 9 p.Article

Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic StudySABA, Nabil F; HURWITZ, Selwyn J; GRIST, William et al.Cancer prevention research (Philadelphia, Pa.). 2014, Vol 7, Num 3, pp 283-291, issn 1940-6207, 9 p.Article

Comparison of survival and hospitalization rates between Medicare patients with advanced NSCLC treated with bevacizumab-carboplatin-paclitaxel and carboplatin-paclitaxel: A retrospective cohort studyLANGER, Corey; RAVELO, Arliene; HAZARD, Sebastien J et al.Lung cancer. 2014, Vol 86, Num 3, pp 350-357, issn 0169-5002, 8 p.Article

A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II doseHOLEN, Kyle D; BELANI, Chandra P; HO, Peter T. C et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 2, pp 447-454, issn 0344-5704, 8 p.Article

Gender and Ethnic Disparities in Incidence and Survival of Squamous Cell Carcinoma of the Oral Tongue, Base of Tongue, and Tonsils: A Surveillance, Epidemiology and End Results Program-Based AnalysisSABA, Nabil F; GOODMAN, Michael; KHURI, Fadlo R et al.Oncology. 2011, Vol 81, Num 1, pp 12-20, issn 0030-2414, 9 p.Article

Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in adult patients with solid tumorsAREGBE, Abdulateef O; SHERER, Eric A; EGORIN, Merrill J et al.Cancer chemotherapy and pharmacology. 2012, Vol 70, Num 1, pp 201-205, issn 0344-5704, 5 p.Article

Effect of the CYP3A Inhibitor Ketoconazole on the Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Advanced Solid Tumors: A Prospective, Multicenter, Open-Label, Randomized, Two-Way Crossover Drug-Drug Interaction StudyVENKATAKRISHNAN, Karthik; RADER, Michael; NEUWIRTH, Rachel et al.Clinical therapeutics. 2009, Vol 31, Num THEM, pp 2444-2458, issn 0149-2918, 15 p., 2Article

Randomized, Phase III Study of Weekly Paclitaxel in Combination With Carboplatin Versus Standard Every-3-Weeks Administration of Carboplatin and Paclitaxel for Patients With Previously Untreated Advanced Non-Small-Cell Lung CancerBELANI, Chandra P; RAMALINGAM, Suresh; PERRY, Michael C et al.Journal of clinical oncology. 2008, Vol 26, Num 3, pp 468-473, issn 0732-183X, 6 p.Article

Single agent maintenance therapy for advanced stage non-small cell lung cancer: A meta-analysisBEHERA, Madhusmita; OWONIKOKO, Taofeek K; ZHENGJIA CHEN et al.Lung cancer. 2012, Vol 77, Num 2, pp 331-338, issn 0169-5002, 8 p.Article

Lung Cancer in Elderly Patients : An Analysis of the Surveillance, Epidemiology, and End Results DatabaseOWONIKOKO, Taofeek K; RAGIN, Camille C; BELANI, Chandra P et al.Journal of clinical oncology. 2007, Vol 25, Num 35, pp 5570-5577, issn 0732-183X, 8 p.Article

Outcomes for Elderly, Advanced-Stage Non-Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel : Analysis of Eastern Cooperative Oncology Group Trial 4599RAMALINGAM, Suresh S; DAHLBERG, Suzanne E; LANGER, Corey J et al.Journal of clinical oncology. 2008, Vol 26, Num 1, pp 60-65, issn 0732-183X, 6 p.Article